AstraZeneca beat second-quarter profit expectations and reaffirmed its 2026 outlook despite concerns about future growth after a trial setback, as investors await further details on its earnings trajectory. Analysts are mixed but broadly positive, with several buy ratings and a focus on the upcoming Q2 results and oncology-driven revenue, amid a broader market backdrop of cautious trading ahead of earnings.

Business· Jul 24, 2026

Facts from Wikidata (CC0). Image by Virginia Office of the Governor via Wikimedia Commons (CC BY 4.0).

Pascal Soriot

Empresario francés

3miembros1here now

Pregunta a Genius Sitio

Sitio Diario

Feed Debates Acerca de

Sort by

Content type

Últimas noticias y debate sobre Pascal Soriot

Sort by

Content type

Pascal Soriot· Business · 43 sources · Jul 24, 2026Story

AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook

Business· Jul 24, 2026

Facts from Wikidata (CC0). Image by Virginia Office of the Governor via Wikimedia Commons (CC BY 4.0).

Pascal Soriot across IJR

Studio characters

Pascal SoriotAsk the French businessman everything the interviews skip.

Ask Genius by OpenServe about Pascal Soriot Create in Studio Build a game Watch videos

About Pascal Soriot

Sir Pascal Claude Roland Soriot es un empresario australiano nacido en Francia y director ejecutivo de la empresa multinacional farmacéutica y biotecnológica británica-sueca AstraZeneca.

members

here now

Occupation: entrepreneur, veterinarian
Position held: chief executive officer
Citizenship: France
Born: May 23, 1959

Coverage spread L25 / C25 / R50

Everything about Pascal Soriot →

Live room · 1 here

Be the first in the room — members see you arrive.

Join the room

Pascal Soriot across IJR

Studio characters

Pascal SoriotAsk the French businessman everything the interviews skip.

Ask Genius by OpenServe about Pascal Soriot Create in Studio Build a game Watch videos